CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SMMT

Ivonescimab Injection

Phase 3
Summit Therapeutics Inc. (SMMT)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Past
days
SMMTPDUFA
Phase 3✗Negative

FDA PDUFA Date ivonescimab

Ivonescimab Injection
Nov 14
Source
Drug Information

Target Indication

Non-Small Cell Lung Cancer

Clinical Trial

NCT06767514

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.